A clinical trial related to vasopressin has been updated as of November 5, 2026. The study, registered as NCT06259799 and titled "Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students," is listed with a status of completed. The trial phase is designated as not applicable. Vasopressin remains an approved compound in its current regulatory status.
This update reflects only the status change recorded for the trial as of the stated date. No results, outcomes, or efficacy data have been reported in connection with this update. The trial's focus, as named in its title, concerns fluid consumption behavior in a college student population using a smart water bottle intervention.
Readers should note that a completed status indicates the study has concluded its planned activities, but it does not by itself indicate what, if any, findings were produced. Any future publication of results would be reported separately as new information becomes available.
For additional background on vasopressin, including its approved regulatory status and general context, readers can consult the compound overview.